MyFinsight
Home
Blog
About
Short-term marketable
securities
$611,128K
(454.31%↑ Y/Y)
Cash and cash
equivalents
$181,172K
(41.99%↑ Y/Y)
Prepaid expenses and
other current assets
$12,520K
(74.86%↑ Y/Y)
Total current assets
$804,820K
(228.49%↑ Y/Y)
Operating lease,
right-of-use assets
$22,596K
(18.32%↑ Y/Y)
Property and equipment,
net
$4,775K
(-18.38%↓ Y/Y)
Other assets
$1,939K
(-60.12%↓ Y/Y)
Restricted cash
$416K
Total assets
$834,546K
(203.67%↑ Y/Y)
Total liabilities and
stockholders equity
$834,546K
(203.67%↑ Y/Y)
Total stockholders
equity
$532,388K
(243.40%↑ Y/Y)
Total liabilities
$302,158K
(152.26%↑ Y/Y)
Accumulated deficit
-$1,382,177K
(-37.53%↓ Y/Y)
Accumulated other
comprehensive income (loss)
-$770K
(-6023.08%↓ Y/Y)
Additional paid-in capital
$1,850,411K
(75.90%↑ Y/Y)
Convertible senior notes,
net
$223,457K
Total current
liabilities
$59,296K
(1.50%↑ Y/Y)
Operating lease
liabilities, net of current...
$19,315K
(28.33%↑ Y/Y)
Other liabilities
$90K
(-96.18%↓ Y/Y)
Preferred stock,
value-Series BNon Voting...
$35,563K
(-34.25%↓ Y/Y)
Preferred stock,
value-Series ANon Voting...
$29,190K
(-45.77%↓ Y/Y)
Common stock, 0.001 par
value 300,000,000...
$171K
(50.00%↑ Y/Y)
Accrued expenses and
other current...
$50,319K
(25.36%↑ Y/Y)
Accounts payable
$7,488K
(-54.96%↓ Y/Y)
Operating lease
liabilities
$1,489K
(-10.19%↓ Y/Y)
Back
Back
Balance Sheet
Cogent Biosciences, Inc. (COGT)
Cogent Biosciences, Inc. (COGT)
source: myfinsight.com